Cargando…
Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer
BACKGROUND: Preclinical and epidemiological studies indicate a potential chemopreventive role of low-density lipoprotein cholesterol (LDL-C) -lowering drugs in the risks of breast cancer and prostate cancer, but the causality remains unclear. We aimed to evaluate the association of genetically proxi...
Autores principales: | Sun, Lulu, Ding, Huan, Jia, Yiming, Shi, Mengyao, Guo, Daoxia, Yang, Pinni, Wang, Yu, Liu, Fanghua, Zhang, Yonghong, Zhu, Zhengbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840684/ https://www.ncbi.nlm.nih.gov/pubmed/35151363 http://dx.doi.org/10.1186/s13058-022-01508-0 |
Ejemplares similares
-
Association between human blood metabolome and the risk of breast cancer
por: Wang, Yu, et al.
Publicado: (2023) -
Intercellular adhesion molecule 4 and ischemic stroke: a two-sample Mendelian randomization study
por: Sun, Lulu, et al.
Publicado: (2023) -
Association between Genetically Proxied Inhibition of HMG-CoA Reductase and Age at Onset of Huntington’s Disease
por: Zhu, Yahui, et al.
Publicado: (2022) -
Predictive Modeling
of HMG-CoA Reductase Inhibitory
Activity and Design of New HMG-CoA Reductase Inhibitors
por: Samizo, Shigeyoshi, et al.
Publicado: (2023) -
Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study
por: Xu, Qingyun, et al.
Publicado: (2023)